Clinical Trials Directory

Trials / Completed

CompletedNCT03141567

LYmphangiogenesis FacTors in Heart Failure States

LYmphangiogenesis FacTors in Heart Failure States (LYFT-HF Study)

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Heart failure often causes fluid to accumulate in the body, leading to congestion and swelling. However, some people who have had heart failure for a long time seem to have very little congestion or swelling, even when the heart failure is poorly treated. The investigators think that this is because lymphatic vessels are able to grow and remove fluid to prevent congestion. The investigators do not know how lymphatic vessels grow. This study will investigate the blood levels of various proteins to try to figure out how the lymph vessels of people with long-standing heart failure might grow.

Conditions

Timeline

Start date
2017-05-18
Primary completion
2021-02-03
Completion
2023-01-24
First posted
2017-05-05
Last updated
2023-07-14

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03141567. Inclusion in this directory is not an endorsement.

LYmphangiogenesis FacTors in Heart Failure States (NCT03141567) · Clinical Trials Directory